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Background
Kaposi’s sarcoma (KS) is the now most important
AIDS-defining malignancy in sub-Saharan Africa includ-
ing Tanzania, and human herpesvirus-8 (HHV-8) is
necessary for its development. Detecting HHV-8 in
biopsies and its antibodies in sera allows the confirma-
tion of KS diagnosis and predicts its risk among blood
transfusion (BT) and organ transplant recipients but
this is not yet routine in most African countries. This
impedes the provision of safe BT/organ donation as
well as KS prevention. A cost-effective HHV-8 serologi-
cal assay for routine use will help improve blood/organ
safety and lower iatrogenic KS incidence in resource-
poor countries.
Materials and methods
Consecutive archival (1990-2001) biopsies and their cor-
responding sera from African patients with KS, non-KS
tumors, and non-neoplastic (reactive) lesions at Muhim-
bili National Hospital (MNH) were evaluated by histo-
pathology, immunohistochemistry (IHC) for the HHV-8
latency-associated nuclear antigen (LANA), and serology
for HIV and HHV-8 (ELISA) as well as for HHV-8
[immunofluorescence (IFA)].
Results
A total of 184 biopsies and corresponding sera from 120
KS (65%), 24 non-KS tumors (13%), and 40 non-neo-
plastic lesions (22%) were evaluated. Most sera (89.0%,
164/184) were HHV-8+ by either IFA or ELISA
(p<0.001, highly statistically significant, Chi
2 Test) and
as expected the majority (68.3%, 112/164) were KS.
HHV-8 serology tests by IFA and ELISA were mostly
(92.4%, 73/79) concordant. Sensitivity, positive predictive
value (PPV), and specificity were 98.6%, 93.5%, and
16.7% for IFA and 93.5%, 98.6%, and 50.0% for ELISA,
respectively. All patients with early-stage KS were HHV-
8 seropositive but two late-stage cases were seronegative
despite LANA expression in their corresponding
biopsies.
Conclusions
HHV-8 frequency at MNH appears to be very high and
necessitates routine screening of blood/organ donors
and recipients to prevent viral transmission and lower
risk of iatrogenic KS development. IFA and ELISA sero-
logy tests appeared highly concordant and ELISA
showed higher PPV and specificity in detecting anti-
HHV-8 antibodies. Thus ELISA might allow affordable
HHV-8 screening in resource-poor countries like Tanza-
nia, with most lacking the cell culture and fluorescence
microscopy facilities needed in IFA. The apparent tissue
(LANA)-serum HHV-8 antibodies discrepancy in late-
stage KS suggests that serum HHV-8 might not be a
good indicator of this tumor’s development.
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